Efficacy and Safety of Pactimibe in Patients With Atherosclerosis
NCT00185146 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2007-03-28
Summary
The effect of pactimibe on the reduction of atherosclerosis in the carotid artery will be assessed using carotid ultrasound
Conditions
Interventions
- DRUG
-
Pactimibe
Sponsors & Collaborators
-
Sankyo Pharma Gmbh
lead INDUSTRY
Principal Investigators
-
P U Witte, MD, PhD, FFPM · IMFORM GmbH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-09-30
- Completion
- 2005-08-31
Countries
- Germany
Study Locations
More Related Trials
-
A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack
NCT07301034 ·Status: RECRUITING ·Phase: PHASE3
-
Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation
NCT02378064 ·Status: COMPLETED ·Phase: PHASE4
-
Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation
NCT03187197 ·Status: COMPLETED
-
Biomarkers and Unstable Carotid Plaque
NCT06887894 ·Status: RECRUITING
-
Single-center, Prospective Cohort Study of PD-1 Inhibitors on Clinical Outcomes of Carotid Plaques in Tumor Patients
NCT05549336 ·Status: UNKNOWN
-
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
NCT01059682 ·Status: TERMINATED ·Phase: PHASE3
-
PCSK9 Inhibitor for Intracranial Atherosclerotic Symptomatic Stenosis
NCT07119918 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty
NCT00269906 ·Status: COMPLETED ·Phase: PHASE3
-
SB-659032 Platelet Aggregation Study
NCT01745458 ·Status: COMPLETED ·Phase: PHASE1
-
Atherosclerosis in the Coronary and Carotid Arteries
NCT00080587 ·Status: COMPLETED
-
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
NCT03248401 ·Status: COMPLETED ·Phase: PHASE4
-
Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.
NCT00307307 ·Status: COMPLETED ·Phase: PHASE4
-
Carotid Atherosclerosis: MEtformin for Insulin ResistAnce Study
NCT00723307 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Small Interfering RNA Inclisiran on Carotid Plaques As Assessed by Carotid Ultrasound
NCT06586684 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients
NCT00734032 ·Status: COMPLETED ·Phase: PHASE2
-
GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease
NCT02377336 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease
NCT00655473 ·Status: COMPLETED ·Phase: PHASE2
-
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
NCT01178320 ·Status: COMPLETED
-
Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?
NCT02983214 ·Status: COMPLETED ·Phase: PHASE4
-
Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis
NCT02124928 ·Status: UNKNOWN
-
Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography
NCT04338165 ·Status: UNKNOWN ·Phase: PHASE2
-
Integrated Biomarker And Imaging Study - 2
NCT00268996 ·Status: COMPLETED ·Phase: PHASE2
-
Carotid Atherosclerotic Plaque Study
NCT00214006 ·Status: COMPLETED
-
Study Effect of VIA-2291 on Atherosclerotic Vascular Inflammation in Patients Undergoing Elective Carotid Endarterectomy
NCT00352417 ·Status: COMPLETED ·Phase: PHASE2
-
Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery Disease (IMPROVE-Ischemia)
NCT04826172 ·Status: COMPLETED ·Phase: PHASE2